May 9th 2024
Stating low demand, the company is removing their ChAdOx1-S [recombinant] (Vaxzevria) vaccine from the market.
CDC ACIP Votes to Recommend an Additional Dose of COVID-19 Vaccine in Seniors
February 28th 2024With today's vote, the federal agency’s Advisory Committee on Immunization Practices (ACIP) is now recommending people 65 years of age and older get 1 more dose of the 2023-2024 formula of the COVID-19 vaccine.
Read More